Company / Operating Cash Flow per Share
Larimar Therapeutics, Inc. Operating Cash Flow per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.17
FY2019
5-year range
-$2.18 / -$0.66
FY2015-FY2019
Trend
+37.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.18 to $-1.17 over the past 2 years.
Based on SEC 10-K filings.
-1.17 in FY2019.
Improved from $-2.18 to $-1.17 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating cash flow per share increased 37.9% year-over-year.
- Peak operating cash flow per share was recorded in FY2015.
- Lowest operating cash flow per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$1.17 | +37.9% |
| FY2018 | -$1.89 | +13.2% |
| FY2017 | -$2.18 | -110.2% |
| FY2016 | -$1.04 | -58.1% |
| FY2015 | -$0.66 | +96.5% |
| FY2014 | -$18.63 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026